Institutional investors hold a majority ownership of AMGN through the 81.41% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DEUTSCHE ASSET MANAGEMENT INVEST... Bought 3.5 Million shares of Amgen Inc
D. E. SHAW & CO. LP Bought 823.3 Thousand shares of Amgen Inc
AQR CAPITAL MANAGEMENT LLC Bought 714.9 Thousand shares of Amgen Inc